NEWCELX LTD (NCEL) Fundamental Analysis & Valuation

NASDAQ:NCEL • CH1442297896

Current stock price

4.41 USD
+0.99 (+28.95%)
At close:
4.35 USD
-0.06 (-1.36%)
After Hours:

This NCEL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NCEL Profitability Analysis

1.1 Basic Checks

  • NCEL had negative earnings in the past year.
  • NCEL had a negative operating cash flow in the past year.
  • NCEL had negative earnings in each of the past 5 years.
  • In the past 5 years NCEL always reported negative operating cash flow.
NCEL Yearly Net Income VS EBIT VS OCF VS FCFNCEL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

  • NCEL has a worse Return On Assets (-143.26%) than 83.88% of its industry peers.
  • Looking at the Return On Equity, with a value of -215.58%, NCEL is doing worse than 72.23% of the companies in the same industry.
Industry RankSector Rank
ROA -143.26%
ROE -215.58%
ROIC N/A
ROA(3y)-339.54%
ROA(5y)-292.49%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NCEL Yearly ROA, ROE, ROICNCEL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for NCEL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NCEL Yearly Profit, Operating, Gross MarginsNCEL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. NCEL Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for NCEL has been increased compared to 1 year ago.
  • NCEL has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for NCEL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NCEL Yearly Shares OutstandingNCEL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 100K 200K 300K
NCEL Yearly Total Debt VS Total AssetsNCEL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

  • NCEL has an Altman-Z score of -19.56. This is a bad value and indicates that NCEL is not financially healthy and even has some risk of bankruptcy.
  • NCEL has a worse Altman-Z score (-19.56) than 83.50% of its industry peers.
  • NCEL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -19.56
ROIC/WACCN/A
WACCN/A
NCEL Yearly LT Debt VS Equity VS FCFNCEL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

  • NCEL has a Current Ratio of 2.77. This indicates that NCEL is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.77, NCEL is doing worse than 65.44% of the companies in the same industry.
  • NCEL has a Quick Ratio of 2.77. This indicates that NCEL is financially healthy and has no problem in meeting its short term obligations.
  • NCEL has a Quick ratio of 2.77. This is in the lower half of the industry: NCEL underperforms 63.30% of its industry peers.
Industry RankSector Rank
Current Ratio 2.77
Quick Ratio 2.77
NCEL Yearly Current Assets VS Current LiabilitesNCEL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. NCEL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 69.65% over the past year.
EPS 1Y (TTM)69.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.07%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y97.19%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NCEL Yearly EPS VS EstimatesNCEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200

More info and screens

Find the best growth stocksShow best growing peers

0

4. NCEL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NCEL. In the last year negative earnings were reported.
  • Also next year NCEL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NCEL Price Earnings VS Forward Price EarningsNCEL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NCEL Per share dataNCEL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NCEL Dividend Analysis

5.1 Amount

  • NCEL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NCEL Fundamentals: All Metrics, Ratios and Statistics

NEWCELX LTD

NASDAQ:NCEL (4/30/2026, 8:07:14 PM)

After market: 4.35 -0.06 (-1.36%)

4.41

+0.99 (+28.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)05-16
Earnings (Next)N/A
Inst Owners1.32%
Inst Owner Change0%
Ins Owners60.24%
Ins Owner Change0%
Market Cap20.11M
Revenue(TTM)N/A
Net Income(TTM)-6.21M
Analysts43.33
Price TargetN/A
Short Float %3.74%
Short Ratio1.3
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 6.98
P/tB 6.98
EV/EBITDA N/A
EPS(TTM)-20.39
EYN/A
EPS(NY)-0.46
Fwd EYN/A
FCF(TTM)-1.06
FCFYN/A
OCF(TTM)-1.06
OCFYN/A
SpS0
BVpS0.63
TBVpS0.63
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -143.26%
ROE -215.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-339.54%
ROA(5y)-292.49%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.77
Quick Ratio 2.77
Altman-Z -19.56
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)39.39%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.07%
EPS Next Y97.19%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y46.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y64.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y64.38%
OCF growth 3YN/A
OCF growth 5YN/A

NEWCELX LTD / NCEL Fundamental Analysis FAQ

What is the fundamental rating for NCEL stock?

ChartMill assigns a fundamental rating of 1 / 10 to NCEL.


Can you provide the valuation status for NEWCELX LTD?

ChartMill assigns a valuation rating of 0 / 10 to NEWCELX LTD (NCEL). This can be considered as Overvalued.


What is the profitability of NCEL stock?

NEWCELX LTD (NCEL) has a profitability rating of 0 / 10.


What is the earnings growth outlook for NEWCELX LTD?

The Earnings per Share (EPS) of NEWCELX LTD (NCEL) is expected to grow by 97.19% in the next year.